Numbness and tingling on peptides: what to track, when it shows up, and how to log it
Numbness and tingling, called paresthesia on labels, is reported by many people on growth hormone secretagogues such as ipamorelin, CJC-1295, sermorelin and MK-677, usually in the hands and fingers. The Egrifta (tesamorelin) label lists paresthesia at 5% versus 2% on placebo and hypoesthesia at 4% versus 2%, and names carpal tunnel syndrome as a fluid retention reaction. Log where, when and a 1–5 score.
Peptide numbness and tingling: what it is and who reports it
Peptide numbness and tingling is the pins and needles in the fingers at night, the hand that has "gone to sleep" on waking, the fingertips that feel slightly wrapped in cotton. Labels call it paresthesia (abnormal sensation) and hypoesthesia (reduced sensation). It is reported mostly with the growth hormone secretagogues: Ipamorelin, CJC-1295 / Ipamorelin, CJC-1295 (no DAC), Sermorelin, Tesamorelin and the oral MK-677. It is not a notable reaction on the GLP-1 labels.
The one label in the group is Egrifta SV (tesamorelin). Its 26-week table lists paresthesia in 5% of patients versus 2% on placebo, and hypoesthesia in 4% versus 2%. More useful than the numbers is the mechanism its warnings section gives: fluid retention from GH secretion "manifests as increased tissue turgor and musculoskeletal discomfort resulting in adverse reactions (e.g. edema, arthralgia, and carpal tunnel syndrome) which are either transient or resolve with discontinuation of treatment." Carpal tunnel syndrome is the median nerve being squeezed at the wrist, and its signature is numbness in the thumb, index and middle fingers, worst at night.
Ipamorelin, CJC-1295, MK-677 and the GHRPs are research compounds with no label and no rate. Sermorelin has no current prescribing information on DailyMed. So the honest framing is that many people report hand tingling on these compounds, that it fits the tesamorelin label's fluid retention picture, and that nobody has measured it for them. It usually travels with water retention and joint pain, which is why Peppy lets you score all three side by side.
When it tends to show up
Many people report tingling starting one to three weeks after beginning a GH secretagogue, or in the week after a dose increase, and that it is worst overnight or first thing in the morning. Night-time dosing and fluid settling while lying down both point the same way. Hands and fingers are named far more than feet.
Many also report it fades: easier after a few weeks, or gone during an off block. The Egrifta label's "transient or resolve with discontinuation" matches that. If yours does not follow that shape, or if it is spreading or turning into weakness, that changes it from a tracking question into a prescriber question.
Two other things can look similar and are worth telling apart in the note. A brief zing or numb patch at the injection site is mechanical, and belongs under injection site reaction. Light-headedness with tingling around the mouth or in the hands can be a blood sugar or dehydration signal; score dizziness too if that is what you feel.
What is worth logging
- Severity, 1–5, every morning. A 1 is a few seconds of pins and needles on waking; a 5 is numbness that lasts into the day or wakes you at night.
- Where, exactly, in the note. "Right thumb and index finger", "both hands", "left foot". Which fingers is the single most useful detail for a prescriber, because it points to which nerve.
- Time of day it is worst. Night and morning suggest the wrist. All-day or spreading suggests something else.
- Days since your shot and the dose. Automatic once the shot is logged in the same app.
- Water retention and joint pain alongside. Score both. Three rows rising together after a step-up is the label's picture.
- Sleeping position, keyboard hours, in the note. A wrist bent under a pillow all night tingles on its own. Context keeps the log honest.
When to contact your prescriber
- Sudden numbness on one side, in the face, or with slurred speech, confusion or weakness. That is a stroke warning. Emergency care, not a log entry.
- Numbness that is spreading, or comes with muscle weakness such as dropping things or a weak grip.
- Numbness with loss of bladder or bowel control, or in a saddle pattern. Same-day call.
- Hand numbness that is not fading after a few weeks, or waking you every night. The Egrifta label ties carpal tunnel to fluid retention and says it resolves on stopping. Whether to change anything is your prescriber's decision. Bring the log with the finger pattern in the notes.
- Diabetes, thyroid disease or a known nerve condition. New tingling on a GH secretagogue is worth a call regardless of how mild it is.
How to do this in Peppy
- Turn numbness / tingling on. Open Settings ▸ Tracking and toggle Numbness / tingling. It is off by default. Toggle Water retention and Joint pain in the same list so all three show on one chart.
- Score it every morning in the daily check-in. On the Today tab tap the check-in row. Set numbness / tingling 1–5 and put the finger pattern and time of day in the note. Score your sleep feeling too, since night-time tingling and poor sleep tend to travel together.
- Log every shot on the body map. Tap the dose on the Today tab, tap the site on the silhouette, confirm the time. If you felt a zing at the site, put that in the shot note rather than the check-in.
- Mark dose changes with the titration ladder (Pro). In the protocol editor, enter the dose steps and durations. Peppy auto-advances the dose on cards and the log sheet, and each step becomes a marker on the Progress charts.
- Read the weekly heat-map in Progress (Pro). Numbness, water retention and joint pain sit as rows on the same week axis with step-ups and cycle boundaries marked. Free users see the chart blurred.
- Use the Calendar for the off-cycle test. If you run cycles (Pro), the week strip shows the skipped days. Compare check-in scores in the off block against the on block.
- Export before an appointment (Pro). Settings ▸ Export produces a PDF or CSV with every check-in note, so "right thumb and index, worst at 3 am" is in front of your prescriber.
Related: water retention, joint pain, the CJC-1295 / ipamorelin tracker and the side-effects tracking guide.
Track it in Peppy
123 compounds built in, the units math done for you, body-map site rotation and reminders — private on your iPhone.
Free · iPhone · no accountFrequently asked
Does ipamorelin cause tingling in the hands?
Ipamorelin is a research compound with no FDA label, so no rate exists. Many people report pins and needles or numb fingertips, often at night or on waking, in the first weeks. The Egrifta tesamorelin label's explanation, fluid retention pressing on nerves as in carpal tunnel syndrome, is the usual reason offered, but it has not been measured for ipamorelin.
Why do growth hormone peptides cause numbness?
The Egrifta label says fluid retention from increased GH secretion causes increased tissue turgor, listing carpal tunnel syndrome among the resulting reactions. Swollen tissue in the wrist can compress the median nerve, which produces numbness in the thumb, index and middle fingers. That is the label's account for tesamorelin; for other GH secretagogues it is an analogy.
Is tingling from peptides permanent?
The Egrifta label says its fluid retention reactions, including carpal tunnel syndrome, are either transient or resolve with discontinuation of treatment. Many people on research GH secretagogues report tingling easing over weeks or clearing during an off cycle. Persistent numbness or weakness is a reason to see your prescriber rather than wait.
Can a peptide injection itself cause numbness at the site?
A small area of numbness or a brief shooting sensation right where the needle went in is something many people describe occasionally; it usually settles within hours. Peppy tracks that under injection site reaction, with the site logged on the body map. Tingling in the hands or feet away from the site is what this page is about.
When is numbness on a peptide an emergency?
Sudden numbness on one side of the body, in the face, or with slurred speech, confusion or weakness is a stroke warning and needs emergency care, whatever you are taking. Numbness that spreads, comes with muscle weakness, or affects bladder or bowel control needs a same-day call.
Not medical advice. Peppy is a tracking tool, not medical advice. Dose calculations are mathematical conversions only. Always follow your prescriber's instructions and verify every draw-up yourself.